|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/519 | |
| A61K 45/06 | |||
| A61P 35/00 |
| (11) | Patento numeris | 2976086 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14768267.8 |
| Europos patento paraiškos padavimo data | 2014-03-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2016-01-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-10-14 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2014/031442 |
| Data | 2014-03-21 |
| (87) | Numeris | WO 2014/153509 |
| Data | 2014-09-25 |
| (30) | Numeris | Data | Šalis |
| 201361804314 P | 2013-03-22 | US |
| (72) |
BRAKE, Rachel, US
NIU, Huifeng, US
|
| (73) |
Millennium Pharmaceuticals, Inc.,
40 Landsdowne Street, Cambridge, MA 02139,
US
|
| (54) | COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |
| COMBINATION OF CATALYTIC MTORC 1/2 INHIBITORS AND SELECTIVE INHIBITORS OF AURORA A KINASE |